Related references
Note: Only part of the references are listed.Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome
Pietro Ravani et al.
KIDNEY INTERNATIONAL (2013)
Rituximab therapy in nephrotic syndrome: implications for patients' management
Aditi Sinha et al.
NATURE REVIEWS NEPHROLOGY (2013)
Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome
Shuichi Ito et al.
PEDIATRIC NEPHROLOGY (2013)
Neutropenia after rituximab treatment: new insights on a late complication
Ofir Wolach et al.
CURRENT OPINION IN HEMATOLOGY (2012)
Late-onset neutropenia following primary treatment of diffuse large B-cell lymphoma with rituximab-containing therapy
Samo Rozman et al.
LEUKEMIA & LYMPHOMA (2012)
Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome
Markus J. Kemper et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center
E. Besada et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2012)
Late-Onset Neutropenia Following Rituximab Therapy in Rheumatic Diseases: Association With B Lymphocyte Depletion and Infections
Daniel Tesfa et al.
ARTHRITIS AND RHEUMATISM (2011)
Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial
Pietro Ravani et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Rituximab associated neutropenia: Description of three cases and an insight into the underlying pathogenesis
Alina Weissmann-Brenner et al.
MEDICAL SCIENCE MONITOR (2011)
Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor Fc gamma RIIIa 158(V/F) polymorphism
Szu-Chin Li et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome: Multicentric Report
Ashima Gulati et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Wen-Kai Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Late-Onset Neutropenia After Rituximab Treatment Case Series and Comprehensive Review of the Literature
Ofir Wolach et al.
MEDICINE (2010)
Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma
Gillianne Geet Yi Lai et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
A Multicenter Survey of Rituximab Therapy for Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Rachel B. Jones et al.
ARTHRITIS AND RHEUMATISM (2009)
Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children
Koichi Kamei et al.
PEDIATRIC NEPHROLOGY (2009)
Late-onset neutropenia following viral bone marrow depression after rituximab therapy
Maximilian Christopeit et al.
ANNALS OF HEMATOLOGY (2008)
Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia
K. Stamatopoulos et al.
LEUKEMIA (2008)
Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis
Daniel Tesfa et al.
MEDICAL ONCOLOGY (2008)
Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases
R. Rios-Fernandez et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Systematic review: Agranulocytosis induced by nonchemotherapy drugs
Frank Andersohn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery
B. Terrier et al.
HAEMATOLOGICA (2007)
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
E. Nitta et al.
ANNALS OF ONCOLOGY (2007)
Parvovirus B19 reactivation presenting as neutropenia after rituximab treatment
A. Klepfish et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Late-onset neutropenia in patients treated with rituximab for non-Hodgkin's lymphoma
Kenji Fukuno et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Delayed-onset peripheral blood cytopenia after rituximab: Frequency and risk factor assessment in a consecutive series of 77 treatments
Chiara Cattaneo et al.
LEUKEMIA & LYMPHOMA (2006)
B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis
K Dunleavy et al.
BLOOD (2005)
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma
B Lemieux et al.
BONE MARROW TRANSPLANTATION (2004)
Delayed-onset neutropenia associated with rituximab therapy
K Chaiwatanatorn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases
T Papadaki et al.
LEUKEMIA RESEARCH (2002)
Share Paper
